AGTR1 and hypertensive disorder: In the treatment of hypertension, especially in high-risk populations or with cardiovascular comorbidities, AT1 receptor of angiotensin II blockers provide reduction of cardiovascular morbidity and mortality and have a cerebrovascular protective effect superior to other antihypertensives, justifying the growing prescription of this pharmacological class.